Comparison of two benzodiazepines used for sedation of children undergoing suturing of a laceration in an emergency department.
Ian J Everitt, Peter Barnett
https://pubmed.ncbi.nlm.nih.gov/11973494/Actively Recruiting
Led by University of Oklahoma · Updated on 2024-06-28
90
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are investigating the use of three intranasal medicationsMidazolam, Dexmedetomidine, and Ketamineto improve anxiety relief and reduce emergency department stay times during minor procedures in young children aged 1 to 5 years. The study aims to identify which medication provides the shortest stay and highest satisfaction for patients and providers. This research is important because pain in young children is often under-recognized due to their limited ability to describe it, and improving medication options could enhance care quality and family experience. The study compares three drugs delivered through the nose to avoid needles and provide quick absorption Midazolam, a common sedative with some side effects Dexmedetomidine, which mimics sleep and is often preferred for children with behavioral concerns and Ketamine, which provides both sedation and pain relief. Each medication is given based on the childs weight, and participants are randomly assigned to receive one of the three. Dosages vary per medication, with Midazolam and Ketamine doses capped at 10mg and 100mg respectively, and Dexmedetomidine capped at 100mcg. The study uses a masked design, so neither the patient nor providers know which drug is given. Participants will be monitored during their emergency department visit as the research team measures the time it takes from medication administration to discharge. They will also assess the childs anxiety using a validated scale and gather satisfaction ratings from both parents and physicians. The study is expected to run until mid-2025, with all procedures and assessments completed on the day of treatment. This approach helps evaluate which medication best balances quick recovery and positive experiences for children undergoing minor procedures.
CONDITIONS
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
G
Gavely Toor, DO
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Oklahoma
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Intranasal Midazolam | Intranasal Dexmedetomidine | Intranasal Ketamine | Standard Intranasal Midazolam Use |
|---|---|---|---|---|
| What it is | Intranasal midazolam given for procedural sedation in pediatric laceration repair (trial arm) | Intranasal dexmedetomidine given for procedural sedation in pediatric laceration repair (trial arm) | Intranasal ketamine given for procedural sedation in pediatric laceration repair (trial arm) | Intranasal midazolam is commonly used for procedural sedation in pediatric emergency settings, especially laceration repair |
| Role in trial | One of three randomized sedation arms | One of three randomized sedation arms | One of three randomized sedation arms | Represents common sedation practice outside of trial design |
| Primary use | Used as intranasal anxiolytic for suture procedures in pediatric ED | Used as intranasal sedative for laceration repair in pediatric ED | Used as intranasal sedative for laceration repair in pediatric ED | Used for intranasal sedation/anxiolysis in pediatric procedures as standard care |
| How it is given | Administered intranasally in small volumes based on weight, randomized by pharmacist | Administered intranasally in small volumes based on weight, randomized by pharmacist | Administered intranasally in small volumes based on weight, randomized by pharmacist | Typically given intranasally by weight for sedation in ED |
| Evidence status | Effectiveness being evaluated in this randomized controlled trial; no published results yet | Effectiveness being evaluated in this randomized controlled trial; no published results yet | Effectiveness being evaluated in this randomized controlled trial; no published results yet | Intranasal midazolam is widely used and supported by retrospective studies as effective for procedural sedation |
| Important risks | Safety profile to be assessed in trial; historical risks include sedation-related respiratory depression | Safety profile to be assessed in trial; historical risks include hypotension and bradycardia | Safety profile to be assessed in trial; historical risks include vomiting and airway effects | Minimal sedation with midazolam has low adverse event rates and allows completion of procedure reliably |
| Important limitations | Trial does not yet have posted results; cannot compare effectiveness or recovery time yet | Trial does not yet have posted results; cannot compare effectiveness or recovery time yet | Trial does not yet have posted results; cannot compare effectiveness or recovery time yet | Retrospective observational data only; not from randomized comparison |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Same day
Participants receive one of three intranasal medications—Midazolam, Dexmedetomidine, or Ketamine—randomly assigned to help reduce anxiety during their procedure.
1 treatment visit
Duration - Same day
Participants are observed for the time from medication administration to discharge. Anxiety levels and satisfaction from parents and physicians are assessed using validated scales.
1 follow-up visit on the day of treatment
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Ian J Everitt, Peter Barnett
https://pubmed.ncbi.nlm.nih.gov/11973494/Prakhar Gyanesh, Rudrashish Haldar, Divya Srivastava...
https://pubmed.ncbi.nlm.nih.gov/23800984/Desiree N W Neville, Katharina R Hayes, Yaron Ivan...
https://pubmed.ncbi.nlm.nih.gov/27129606/Z N Kain, L C Mayes, D V Cicchetti...
https://pubmed.ncbi.nlm.nih.gov/9322455/M Natarajan Surendar, R Kumar Pandey, A Kumar Saksena...
https://pubmed.ncbi.nlm.nih.gov/25095322/Joseph P Cravero, Nissa Askins, Patcharee Sriswasdi...
https://pubmed.ncbi.nlm.nih.gov/28557732/Giorgia Carlone, Andrea Trombetta, Stefano Amoroso...
https://pubmed.ncbi.nlm.nih.gov/31157751/Aslihan Tug, Ayse Hanci, Hacer Sebnem Turk...
https://pubmed.ncbi.nlm.nih.gov/26323489/Reza Azizkhani, Farhad Heydari, Mohammadreza Ghazavi...
https://pubmed.ncbi.nlm.nih.gov/33531939/William T Zempsky, Joseph P Cravero, American Academy of Pediatrics Committee on Pediatric Emergency Medicine and Section on Anesthesiology and Pain Medicine
https://pubmed.ncbi.nlm.nih.gov/15520120/University of Oklahoma
Lead Sponsor